Literature DB >> 15463403

A model for the dynamics of human lymphatic filariasis.

B T Grenfell1, E Michael, D A Denham.   

Abstract

In this paper, Bryan Gren fell, Edwin Michael and David Denham review the appropriateness of feline filariasis as a model of the population dynamics of human lymphatic filarial infection and disease. Because of the longevity of infection and our inability to measure the adult parasite population in humans, research in filariasis is particularly dependent on the use of laboratory animal models. We demonstrate that Brugia pahangi infection patterns in the cat closely parallel those of Brugia and Wuchereria in humans. Although primary infections in 'susceptible' cats are long-lived, repeatedly infected animals show evidence of concomitant immunity which prevents the establishment of later cohorts of infective larvae. Furthermore, there is some evidence from macro filarial length distributions of 'stunting' of adult worms during long-term repeat infections. Cats can also show an 'acute' response that spontaneously eliminates infections, and this appears to be due to a combination of intrinsic and dynamic mechanisms. As in humans, pathology in cat filariasis develops as a sequel to the asymptomatic microfilaremic state, largely as a result of re-expression of immunity. The relationship between macro filarial burdens and microfilariae in blood is positive but portrays a high degree of variability. The cat model provides an important tool for elucidating the relationships between infection, immunity and disease dynamics in lymphatic filariasis, and we conclude by suggesting directions for further work in this area.

Entities:  

Year:  1991        PMID: 15463403     DOI: 10.1016/0169-4758(91)90270-x

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  11 in total

Review 1.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

2.  Population biology of human onchocerciasis.

Authors:  M G Basáñez; M Boussinesq
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

3.  Modelling variability in lymphatic filariasis: macrofilarial dynamics in the Brugia pahangi--cat model.

Authors:  E Michael; B T Grenfell; V S Isham; D A Denham; D A Bundy
Journal:  Proc Biol Sci       Date:  1998-01-22       Impact factor: 5.349

4.  Th1-like antifilarial immune responses predominate in antigen-negative persons.

Authors:  K A Dimock; M L Eberhard; P J Lammie
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Preadult stage parasites and multiple timed exposure to infective larvae are involved in development of limb edema in Brugia malayi-infected Indian leaf monkeys (Presbytis entellus).

Authors:  P K Murthy; M A Khan; H B Rajani; V M L Srivastava
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

6.  Host protective immunity and vaccine development studies in lymphatic filariasis.

Authors:  M V Reddy; R Alli; B C Harinath
Journal:  Indian J Clin Biochem       Date:  2000-08

7.  Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection.

Authors:  Michael M Opata; Robin Stephens
Journal:  Curr Immunol Rev       Date:  2013-08

8.  Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection.

Authors:  Nathan C Peters; Antonio J Pagán; Phillip G Lawyer; Timothy W Hand; Eric Henrique Roma; Lisa W Stamper; Audrey Romano; David L Sacks
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

9.  Caring for patients in the global programme to eliminate lymphatic filariasis.

Authors:  Charles D Mackenzie; Sunny Mante
Journal:  Int Health       Date:  2020-12-22       Impact factor: 2.473

10.  Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection.

Authors:  Michael A Irvine; Sammy M Njenga; Shamini Gunawardena; Claire Njeri Wamae; Jorge Cano; Simon J Brooker; T Deirdre Hollingsworth
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-02       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.